Role of alloreactive KIR2DS1 + NK cells in haploidentical hematopoietic stem cell transplantation

Journal of Leukocyte Biology

Volumn 90, Issue 4, 2011, Pages 661-667

  Marcenaro, Emanuela ^a   Carlomagno, Simona ^a   Pesce, Silvia ^a   della Chiesa, Mariella ^a   Moretta, Alessandro ^a   Sivori, Simona ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

CCR7; GvHD; GvL; HvG; KIR

Indexed keywords

CHEMOKINE RECEPTOR CCR7; HLA ANTIGEN CLASS 1; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DS1; UNCLASSIFIED DRUG;

ALLOIMMUNITY; ANTIGEN SPECIFICITY; CELL MIGRATION; DENDRITIC CELL; GRAFT VERSUS HOST REACTION; HAPLOTYPE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LEUKEMIA CELL; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE;

ACUTE DISEASE; ANIMALS; GENE EXPRESSION REGULATION; GRAFT VS LEUKEMIA EFFECT; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNITY, CELLULAR; KILLER CELLS, NATURAL; LEUKEMIA; RECEPTORS, CCR7; RECEPTORS, KIR; TRANSPLANTATION, HOMOLOGOUS;

EID: 80053376322     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0311137     Document Type: Review

References (63)

1. Moretta, A., Marcenaro, E., Sivori, S., Della Chiesa, M., Vitale, M., Moretta, L. (2005) Early liaisons between cells of the innate immune system in inflamed peripheral tissues. Trends Immunol. 26, 668-675.
2. Vivier, E., Tomasello, E., Baratin, M., Walzer, T., Ugolini, S. (2008) Functions of natural killer cells. Nat. Immunol. 9, 503-510.
3. Parham, P. (2005) MHC class I molecules and KIRs in human history, health and survival. Nat. Rev. Immunol. 5, 201-214.
4. Lanier, L. L. (2005) NK cell recognition. Annu. Rev. Immunol. 23, 225-274.
5. Moretta, A., Bottino, C., Vitale, M., Pende, D., Biassoni, R., Mingari, M. C., Moretta, L. (1996) Receptors for HLA class-I molecules in human natural killer cells. Annu. Rev. Immunol. 14, 619-648.
6. Braud, V. M., Allan, D. S., O'Callaghan, C. A., Soderstrom, K., D'Andrea, A., Ogg, G. S., Lazetic, S., Young, N. T., Bell, J. I., Phillips, J. H., Lanier, L. L., McMichael, A. J. (1998) HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 391, 795-799.
7. Moretta, L., Moretta, A. (2004) Killer immunoglobulin-like receptors. Curr. Opin. Immunol. 16, 626-633.
8. Long, E. O. (1999) Regulation of immune responses through inhibitory receptors. Annu. Rev. Immunol. 17, 875-904.
9. Moretta, L., Locatelli, F., Pende, D., Marcenaro, E., Mingari, M. C., Moretta, A. (2011) Killer Ig-like receptor-mediated control of natural killer cell alloreactivity in haploidentical hematopoietic stem cell transplantation. Blood 117, 764-771.
10. Kärre, K. (2008) Natural killer cell recognition of missing self. Nat. Immunol. 9, 477-480.
11. Moretta, A., Bottino, C., Vitale, M., Pende, D., Cantoni, C., Mingari, M. C., Biassoni, R., Moretta, L. (2001) Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu. Rev. Immunol. 19, 197-223.
12. Agaugué, S., Marcenaro, E., Ferranti, B., Moretta, L., Moretta, A. (2008) Human natural killer cells exposed to IL-2, IL-12, IL-18, or IL-4 differently modulate priming of naive T cells by monocyte-derived dendritic cells. Blood 112, 1776-1783.
13. Marcenaro, E., Della Chiesa, M., Bellora, F., Parolini, S., Millo, R., Moretta, L., Moretta, A. (2005) IL-12 or IL-4 prime human NK cells to mediate functionally divergent interactions with dendritic cells or tumors. J. Immunol. 174, 3992-3998.
14. Sivori, S., Falco, M., Della Chiesa, M., Carlomagno, S., Vitale, M., Moretta, L., Moretta, A. (2004) CpG and double-stranded RNA trigger human NK cells by Toll-like receptors: induction of cytokine release and cytotoxicity against tumors and dendritic cells. Proc. Natl. Acad. Sci. USA 101, 10116-10121.
15. Marcenaro, E., Ferranti, B., Falco, M., Moretta, L., Moretta, A. (2008) Human NK cells directly recognize Mycobacterium bovis via TLR2 and acquire the ability to kill monocyte-derived DC. Int. Immunol. 20, 1155-1167.
16. Sivori, S., Falco, M., Carlomagno, S., Romeo, E., Moretta, L., Moretta, A. (2007) Heterogeneity of TLR3 mRNA transcripts and responsiveness to poly (I:C) in human NK cells derived from different donors. Int. Immunol. 19, 1341-1348.
17. Sivori, S., Carlomagno, S., Moretta, L., Moretta, A. (2006) Comparison of different CpG oligodeoxynucleotide classes for their capability to stimulate human NK cells. Eur. J. Immunol. 36, 961-967.
18. Middleton, D., Menchaca, L., Rood, H., Komerofsky, R. (2003) New allele frequency database: http://www.allelefrequencies.net. Tissue Antigens 61, 403-407.
19. Uhrberg, M., Valiante, N. M., Shum, B. P., Shilling, H. G., Lienert-Weidenbach, K., Corliss, B., Tyan, D., Lanier, L. L., Parham, P. (1997) Human diversity in killer cell inhibitory receptor genes. Immunity 7, 753-763.
20. Hsu, K. C., Liu, X. R., Selvakumar, A., Mickelson, E., O'Reilly, R. J., Dupont, B. (2002) Killer Ig-like receptor haplotype analysis by gene content: evidence for genomic diversity with a minimum of six basic framework haplotypes, each with multiple subsets. J. Immunol. 169, 5118-5129.
21. Yawata, M., Yawata, N., Abi-Rached, L., Parham, P. (2002) Variation within the human killer cell immunoglobulin-like receptor (KIR) gene family. Crit. Rev. Immunol. 22, 463-482.
22. Moretta, A., Vitale, M., Bottino, C., Orengo, A. M., Morelli, L., Augugliaro, R., Barbaresi, M., Ciccone, E., Moretta, L. (1993) P58 molecules as putative receptors for major histocompatibility complex (MHC) class I molecules in human natural killer (NK) cells. Anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificities. J. Exp. Med. 178, 597-604.
23. Wagtmann, N., Biassoni, R., Cantoni, C., Verdiani, S., Malnati, M. S., Vitale, M., Bottino, C., Moretta, L., Moretta, A., Long, E. O. (1995) Molecu-lar clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains. Immunity 2, 439-449.
24. Colonna, M., Samaridis, J. (1995) Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells. Science 268, 405-408.
25. Lanier, L. L. (1998) NK cell receptors. Annu. Rev. Immunol. 16, 359-393.
26. Trowsdale, J., Barten, R., Haude, A., Stewart, C. A., Beck, S., Wilson, M. J. (2001) The genomic context of natural killer receptor extended gene families. Immunol. Rev. 181, 20-38.
27. Vilches, C., Parham, P. (2002) KIR: diverse, rapidly evolving receptors of innate and adaptive immunity. Annu. Rev. Immunol. 20, 217-251.
28. Moesta, A. K., Norman, P. J., Yawata, M., Yawata, N., Gleimer, M., Parham, P. (2008) Synergistic polymorphism at two positions distal to the ligand-binding site makes KIR2DL2 a stronger receptor for HLA-C than KIR2DL3. J. Immunol. 180, 3969-3979.
29. Sivori, S., Falco, M., Carlomagno, S., Romeo, E., Soldani, C., Bensussan, A., Viola, A., Moretta, L., Moretta, A. (2010) A novel KIR-associated function: evidence that CpG DNA uptake and shuttling to early endosomes is mediated by KIR3DL2. Blood 116, 1637-1647.
30. Moretta, A., Sivori, S., Vitale, M., Pende, D., Morelli, L., Augugliaro, R., Bottino, C., Moretta, L. (1995) Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells. J. Exp. Med. 182, 875-884.
31. Stewart, C. A., Laugier-Anfossi, F., Vely, F., Saulquin, X., Riedmuller, J., Tisserant, A., Gauthier, L., Romagne, F., Ferracci, G., Arosa, F. A., Moretta, A., Sun, P. D., Ugolini, S., Vivier, E. (2005) Recognition of peptide- MHC class I complexes by activating killer immunoglobulin-like receptors. Proc. Natl. Acad. Sci. USA 102, 13224-13229.
32. Chewning, J. H., Gudme, C. N., Hsu, K. C., Selvakumar, A., Dupont, B. (2007) KIR2DS1-positive NK cells mediate alloresponse against the C2 HLA-KIR ligand group in vitro. J. Immunol. 179, 854-868.
33. Graef, T., Moesta, A. K., Norman, P. J., Abi-Rached, L., Vago, L., OlderAguilar, A. M., Gleimer, M., Hammond, J. A., Guethlein, L. A., Bushnell, D. A., Robinson, P. J., Parham, P. (2009) KIR2DS4 is a product of gene conversion with KIR3DL2 that introduced specificity for HLA-A*11 while diminishing avidity for HLA-C. J. Exp. Med. 206, 2557-2572.
34. Vivier, E., Raulet, D. H., Moretta, A., Caligiuri, M. A., Zitvogel, L., Lanier, L. L., Yokoyama, W. M., Ugolini, S. (2011) Innate or adaptive immunity? The example of natural killer cells. Science 331, 44-49.
35. Kim, S., Poursine-Laurent, J., Truscott, S. M., Lybarger, L., Song, Y. J., Yang, L., French, A. R., Sunwoo, J. B., Lemieux, S., Hansen, T. H., Yokoyama, W. M. (2005) Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature 436, 709-713.
36. Anfossi, N., Andre, P., Guia, S., Falk, C. S., Roetynck, S., Stewart, C. A., Breso, V., Frassati, C., Reviron, D., Middleton, D., Romagne, F., Ugolini, S., Vivier, E. (2006) Human NK cell education by inhibitory receptors for MHC class I. Immunity 25, 331-342.
37. Joncker, N. T., Fernandez, N. C., Treiner, E., Vivier, E., Raulet, D. H. (2009) NK cell responsiveness is tuned commensurate with the numberof inhibitory receptors for self-MHC class I: the rheostat model. J. Immunol. 182, 4572-4580.
38. Fauriat, C., Ivarsson, M. A., Ljunggren, H. G., Malmberg, K. J., Michaelsson, J. (2010) Education of human natural killer cells by activating killer cell immunoglobulin-like receptors. Blood 115, 1166-1174.
39. Ruggeri, L., Capanni, M., Urbani, E., Perruccio, K., Shlomchik, W. D., Tosti, A., Posati, S., Rogaia, D., Frassoni, F., Aversa, F., Martelli, M. F., Velardi, A. (2002) Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 295, 2097-2100.
40. Pende, D., Spaggiari, G. M., Marcenaro, S., Martini, S., Rivera, P., Capobianco, A., Falco, M., Lanino, E., Pierri, I., Zambello, R., Bacigalupo, A., Mingari, M. C., Moretta, A., Moretta, L. (2005) Analysis of the receptor-ligand interactions in the natural killer-mediated lysis of freshly isolated myeloid or lymphoblastic leukemias: evidence for the involvement of the poliovirus receptor (CD155) and nectin-2 (CD112). Blood 105, 2066-2073.
41. Pende, D., Marcenaro, S., Falco, M., Martini, S., Bernardo, M. E., Montagna, D., Romeo, E., Cognet, C., Martinetti, M., Maccario, R., Mingari, M. C., Vivier, E., Moretta, L., Locatelli, F., Moretta, A. (2009) Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity. Blood 113, 3119-3129.
42. Moretta, A., Locatelli, F., Moretta, L. (2008) Human NK cells: from HLA class I-specific killer Ig-like receptors to the therapy of acute leukemias. Immunol. Rev. 224, 58-69.
43. Rocha, V., Locatelli, F. (2008) Searching for alternative hematopoietic stem celldonors for pediatric patients. Bone Marrow Transplant. 41, 207-214.
44. Gluckman, E. (2006) Cord blood transplantation. Biol. Blood Marrow Transplant. 12, 808-812.
45. Locatelli, F., Pende, D., Maccario, R., Mingari, M. C., Moretta, A., Moretta, L. (2009) Haploidentical hemopoietic stem cell transplantation for the treatment of high-risk leukemias: how NK cells make the difference. Clin. Immunol. 133, 171-178.
46. Ruggeri, L., Aversa, F., Martelli, M. F., Velardi, A. (2006) Allogeneic hematopoietictransplantation and natural killer cell recognition of missing self. Immunol. Rev. 214, 202-218.
47. Velardi, A., Ruggeri, L., Alessandro, Moretta, Moretta, L. (2002) NK cells: a lessonfrom mismatched hematopoietic transplantation. Trends Immunol. 23, 438-444.
48. Stern, M., Ruggeri, L., Mancusi, A., Bernardo, M. E., de Angelis, C., Bucher, C., Locatelli, F., Aversa, F., Velardi, A. (2008) Survival after T celldepletedhaploidentical stem cell transplantation is improved using the mother as donor. Blood 112, 2990-2995.
49. Moretta, A., Bottino, C., Pende, D., Tripodi, G., Tambussi, G., Viale, O., Orengo, A., Barbaresi, M., Merli, A., Ciccone, E., et al. (1990) Identificationof four subsets of human CD3-CD16+ natural killer (NK) cells bythe expression of clonally distributed functional surface molecules: correlation between subset assignment of NK clones and ability to mediatespecific alloantigen recognition. J. Exp. Med. 172, 1589-1598.
50. Bottino, C., Castriconi, R., Moretta, L., Moretta, A. (2005) Cellular ligands of activating NK receptors. Trends Immunol. 26, 221-226.
51. Costello, R. T., Sivori, S., Marcenaro, E., Lafage-Pochitaloff, M., Mozziconacci, M. J., Reviron, D., Gastaut, J. A., Pende, D., Olive, D., Moretta, A. (2002) Defective expression and function of natural killer cell-triggering receptors in patients with acute myeloid leukemia. Blood 99, 3661-3667.
52. Cooley, S., Trachtenberg, E., Bergemann, T. L., Saeteurn, K., Klein, J., Le, C. T., Marsh, S. G., Guethlein, L. A., Parham, P., Miller, J. S., Weisdorf, D. J. (2009) Donors with group B KIR haplotypes improve relapsefree survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia. Blood 113, 726-732.
53. Venstrom, J. M., Gooley, T. A., Spellman, S., Pring, J., Malkki, M., Dupont, B., Petersdorf, E., Hsu, K. C. (2010) Donor activating KIR3DS1 is associated with decreased acute GVHD in unrelated allogeneic hematopoietic stem cell transplantation. Blood 115, 3162-3165.
54. Verheyden, S., Schots, R., Duquet, W., Demanet, C. (2005) A defined donor activating natural killer cell receptor genotype protects against leukemic relapse after related HLA-identical hematopoietic stem cell transplantation. Leukemia 19, 1446-1451.
55. Shlomchik, W. D., Couzens, M. S., Tang, C. B., McNiff, J., Robert, M. E., Liu, J., Shlomchik, M. J., Emerson, S. G. (1999) Prevention of graft versus host disease by inactivation of host antigen-presenting cells. Science 285, 412-415.
56. Della Chiesa, M., Vitale, M., Carlomagno, S., Ferlazzo, G., Moretta, L., Moretta, A. (2003) The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors. Eur. J. Immunol. 33, 1657-1666.
57. Ferlazzo, G., Tsang, M. L., Moretta, L., Melioli, G., Steinman, R. M., Munz, C. (2002) Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells. J. Exp. Med. 195, 343-351.
58. Pende, D., Castriconi, R., Romagnani, P., Spaggiari, G. M., Marcenaro, S., Dondero, A., Lazzeri, E., Lasagni, L., Martini, S., Rivera, P., Capobianco, A., Moretta, L., Moretta, A., Bottino, C. (2006) Expression of the DNAM-1 ligands, nectin-2 (CD112) and poliovirus receptor (CD155), on dendritic cells: relevance for natural killer-dendritic cell interaction. Blood 107, 2030-2036.
59. Sivori, S., Carlomagno, S., Falco, M., Romeo, E., Moretta, L., Moretta, A. (2011) Natural killer cells expressing the KIR2DS1-activating receptor efficiently kill T-cell blasts and dendritic cells: implications in haploidentical HSCT. Blood 117, 4284-4292.
60. Vitale, M., Sivori, S., Pende, D., Augugliaro, R., Di Donato, C., Amoroso, A., Malnati, M., Bottino, C., Moretta, L., Moretta, A. (1996) Physical and functional independency of p70 and p58 natural killer (NK) cell receptors for HLA class I: their role in the definition of different groups of alloreactive NK cell clones. Proc. Natl. Acad. Sci. USA 93, 1453-1457.
61. Vitale, M., Della Chiesa, M., Carlomagno, S., Romagnani, C., Thiel, A., Moretta, L., Moretta, A. (2004) The small subset of CD56brightCD16-natural killer cells is selectively responsible for both cell proliferation and interferon-γ production upon interaction with dendritic cells. Eur. J. Immunol. 34, 1715-1722.
62. Mailliard, R. B., Alber, S. M., Shen, H., Watkins, S. C., Kirkwood, J. M., Herberman, R. B., Kalinski, P. (2005) IL-18-induced CD83+CCR7+ NK helper cells. J. Exp. Med. 202, 941-953.
63. Marcenaro, E., Cantoni, C., Pesce, S., Prato, C., Pende, D., Agaugue, S., Moretta, L., Moretta, A. (2009) Uptake of CCR7 and acquisition of migratory properties by human KIR+ NK cells interacting with monocytederived DC or EBV cell lines: regulation by KIR/HLA-class I interaction. Blood 114, 4108-4116.